US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Definium Therapeutics

37.40

-0.2000-0.53%

Post-market: 37.34-0.0600-0.16%19:30 EDT

Volume:1.60M

Turnover:59.67M

Market Cap:5.03B

PE:-10.74

High:38.14

Open:37.70

Low:36.86

Close:37.60

52wk High:49.70

52wk Low:10.46

Shares:134.37M

Float Shares:129.97M

Volume Ratio:0.66

T/O Rate:1.23%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.4823

EPS(LYR):-2.0600

ROE:-64.09%

ROA:-20.64%

PB:5.47

PE(LYR):-18.16

Loading ...

Overview Company News Filings

Definium Therapeutics initiated with an Overweight at Wells Fargo

Definium Therapeutics Price Target Raised to $73.00/share from $48.00 by Piper Sandler

Definium Therapeutics price target raised to $73 from $48 at Piper Sandler

U.S. Research Roundup-deckers Brands, Rollins, United Rentals

Movement Alert｜Definium Therapeutics Rises 5.14% in Regular Trading, Trading at $45.02

Definium Therapeutics Issues Options for 30,330 Shares to New Hires Under Inducement Plan

Movement Alert｜Definium Therapeutics Rises 5.5% in Regular Trading, DT120 Phase 3 Data and Sector M&A Fuel Momentum

S&P 500 Futures Decline in Premarket Trading; Ermenegildo Zegna, JB Hunt Transport Lead

Definium Therapeutics Launches Wired for Worry, a Health Care Provider Initiative to Advance the Understanding of Generalized Anxiety Disorder (gad) Patient Impact and Neurobiology

THOMSON REUTERS

Movement Alert｜Definium Therapeutics Rises 5.1% in Pre-Market Trading, DT120 Phase 3 Data and Capital Raise Continue to Fuel Momentum

Movement Alert｜Definium Therapeutics Rises 7.03% Overnight, DT120 Phase 3 Data Momentum Continues

Movement Alert｜Definium Therapeutics Rises 5.04% in After-Hours Trading, Trading at $47.79

Definium Therapeutics (DFTX) Could Be 30% Overvalued After New GAD Study

Simply Wall St.

Will New GAD Treatment Persistence Data Change Definium Therapeutics' (DFTX) Unmet‑Need Narrative?

Simply Wall St.

Movement Alert｜Definium Therapeutics Rises 5.13% in Regular Trading, Trading at $45.845

Definium Therapeutics announces results from healthcare claims study in GAD

Definium Says Claims Study Finds High GAD Drug Discontinuation, Switching Rates

Movement Alert｜Definium Therapeutics Falls 5.44% in Regular Trading, Trading at $44.45

Movement Alert｜Definium Therapeutics Falls 5.06% in Regular Trading, Trading at $45.96

Movement Alert｜Definium Therapeutics Rises 5.09% in Regular Trading, Phase 3 Clinical Success and Major Financing Boost Market Confidence

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/DFTX/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"DFTX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DFTX\",,,,,undefined,":{"symbol":"DFTX","market":"US","secType":"STK","nameCN":"Definium Therapeutics","latestPrice":37.4,"timestamp":1790971200000,"preClose":37.6,"halted":0,"volume":1598751,"hourTrading":{"tag":"盘后","latestPrice":37.34,"preClose":37.4,"latestTime":"19:30 EDT","volume":61050,"amount":2281098.8977,"timestamp":1790983803977,"change":-0.06,"changeRate":-0.001604,"amplitude":0.014706},"delay":0,"changeRate":-0.005319148936170288,"floatShares":129971489,"shares":134366950,"eps":-3.482311,"marketStatus":"Market Closed","change":-0.2,"latestTime":"10-02 16:00:00 EDT","open":37.7,"high":38.14,"low":36.86,"amount":59672162.826738,"amplitude":0.034043,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.482311,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":37.6,"preHourTrading":{"tag":"盘前","latestPrice":37.67,"preClose":37.6,"latestTime":"09:29 EDT","volume":2200,"amount":83076.114,"timestamp":1790947799999,"change":0.07,"changeRate":0.001862,"amplitude":0.019415},"postHourTrading":{"tag":"盘后","latestPrice":37.34,"preClose":37.4,"latestTime":"19:30 EDT","volume":61050,"amount":2281098.8977,"timestamp":1790983803977,"change":-0.06,"changeRate":-0.001604,"amplitude":0.014706},"volumeRatio":0.6580987443165245,"impliedVol":0.6021,"impliedVolPercentile":0.0056},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DFTX\",,,,,undefined,":{"symbol":"DFTX","floatShares":129971489,"roa":"-20.64%","roe":"-64.09%","lyrEps":-2.059999,"volumeRatio":0.6580987443165245,"shares":134366950,"dividePrice":0,"high":38.14,"amplitude":0.034043,"preClose":37.6,"low":36.86,"week52Low":10.4646,"pbRate":"5.47","week52High":49.7,"institutionHeld":0,"latestPrice":37.4,"eps":-3.482311,"divideRate":0,"volume":1598751,"delay":0,"ttmEps":-3.482311,"open":37.7,"prevYearClose":13.39,"prevWeekClose":36.17,"prevMonthClose":38.06,"prevQuarterClose":38.06,"fiveDayClose":36.17,"twentyDayClose":38,"sixtyDayClose":48.45},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DFTX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-06","symbol":"DFTX","fiscalQuarterEnding":"2026/06","expectedEps":-0.55,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1785988800000,"reportTimeType":"post","actualEps":-1.44},{"market":"US","date":"2026-05-07","symbol":"DFTX","fiscalQuarterEnding":"2026/03","expectedEps":-0.47,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"post","actualEps":-0.71},{"market":"US","date":"2026-02-26","symbol":"DFTX","fiscalQuarterEnding":"2025/12","expectedEps":-0.45,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1772082000000,"reportTimeType":"post","actualEps":-0.45}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DFTX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"DFTX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3889,"buy":0.6111,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6111,"analysts":18,"updateTime":1787025600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/DFTX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"DFTX","date":"2026-10-02","current":-10.739994,"percent":0.376404,"low":-27.074722,"twenty":-17.093203,"median":-11.537867,"eighty":-9.941944,"high":-8.802064,"avg":-13.982706,"sd":5.175129,"marketCap":5052197320},"quantilePoints":[{"date":"2026-01-16","current":-9.013032,"twenty":-8.970838,"median":-8.907548,"eighty":-8.844258,"marketCap":1515072711},{"date":"2026-01-23","current":-9.944809,"twenty":-9.944809,"median":-9.423248,"eighty":-8.819645,"marketCap":1671702464},{"date":"2026-01-30","current":-10.103035,"twenty":-10.103035,"median":-9.868626,"eighty":-9.013032,"marketCap":1698299969},{"date":"2026-02-06","current":-9.522872,"twenty":-10.196799,"median":-9.918438,"eighty":-9.522872,"marketCap":1600775783},{"date":"2026-02-13","current":-9.511152,"twenty":-10.179218,"median":-9.944809,"eighty":-9.522872,"marketCap":1598805598},{"date":"2026-02-20","current":-10.120616,"twenty":-10.18039,"median":-9.944809,"eighty":-9.520528,"marketCap":1701255248},{"date":"2026-02-27","current":-9.267085,"twenty":-10.187422,"median":-9.96239,"eighty":-9.520528,"marketCap":1703225433},{"date":"2026-03-06","current":-9.519961,"twenty":-10.18039,"median":-9.903787,"eighty":-9.502065,"marketCap":1749702163},{"date":"2026-03-13","current":-9.753213,"twenty":-10.18039,"median":-9.918437,"eighty":-9.518199,"marketCap":1792572359},{"date":"2026-03-20","current":-10.122078,"twenty":-10.169841,"median":-9.903787,"eighty":-9.52229,"marketCap":1860367087},{"date":"2026-03-27","current":-10.273963,"twenty":-10.169841,"median":-9.918437,"eighty":-9.559599,"marketCap":1888282563},{"date":"2026-04-02","current":-11.174427,"twenty":-10.181562,"median":-9.918437,"eighty":-9.550417,"marketCap":2053781457},{"date":"2026-04-10","current":-11.619234,"twenty":-10.247114,"median":-9.944809,"eighty":-9.57529,"marketCap":2135533923},{"date":"2026-04-17","current":-12.18338,"twenty":-10.396104,"median":-9.980506,"eighty":-9.589394,"marketCap":2239219977},{"date":"2026-04-24","current":-12.617338,"twenty":-11.167918,"median":-10.038572,"eighty":-9.618687,"marketCap":2318978480},{"date":"2026-05-01","current":-11.86876,"twenty":-11.389236,"median":-10.10442,"eighty":-9.643639,"marketCap":2181395062},{"date":"2026-05-08","current":-13.767387,"twenty":-11.71579,"median":-10.122078,"eighty":-9.665202,"marketCap":2530349365},{"date":"2026-05-15","current":-9.802755,"twenty":-11.643102,"median":-10.113211,"eighty":-9.689477,"marketCap":2328575817},{"date":"2026-05-22","current":-10.399644,"twenty":-11.570414,"median":-10.105791,"eighty":-9.636028,"marketCap":2470362634},{"date":"2026-05-29","current":-10.780735,"twenty":-11.483622,"median":-10.120616,"eighty":-9.642537,"marketCap":2560888064},{"date":"2026-06-05","current":-11.290386,"twenty":-11.393576,"median":-10.145827,"eighty":-9.660184,"marketCap":2681952193},{"date":"2026-06-12","current":-11.069996,"twenty":-11.344489,"median":-10.179218,"eighty":-9.68473,"marketCap":2629600138},{"date":"2026-06-18","current":-11.216923,"twenty":-11.349156,"median":-10.196799,"eighty":-9.702279,"marketCap":2664501508},{"date":"2026-06-26","current":-20.565124,"twenty":-11.510745,"median":-10.247973,"eighty":-9.723056,"marketCap":4885101210},{"date":"2026-07-02","current":-24.252692,"twenty":-11.77112,"median":-10.299843,"eighty":-9.753213,"marketCap":5761057223},{"date":"2026-07-10","current":-27.074722,"twenty":-12.069466,"median":-10.333633,"eighty":-9.796609,"marketCap":6431410656},{"date":"2026-07-17","current":-24.643864,"twenty":-12.519698,"median":-10.492938,"eighty":-9.802755,"marketCap":5853977501},{"date":"2026-07-24","current":-23.990048,"twenty":-12.931958,"median":-10.537388,"eighty":-9.812883,"marketCap":5698667894},{"date":"2026-07-31","current":-24.861803,"twenty":-14.440728,"median":-10.67054,"eighty":-9.817222,"marketCap":5905747370},{"date":"2026-08-07","current":-17.312135,"twenty":-19.588062,"median":-10.789918,"eighty":-9.824231,"marketCap":6124773739},{"date":"2026-08-14","current":-16.673146,"twenty":-17.887875,"median":-10.831241,"eighty":-9.831914,"marketCap":5898709105},{"date":"2026-08-21","current":-17.242844,"twenty":-17.526933,"median":-11.058518,"eighty":-9.861594,"marketCap":6100259530},{"date":"2026-08-28","current":-16.642763,"twenty":-17.426666,"median":-11.092954,"eighty":-9.887379,"marketCap":5887959749},{"date":"2026-09-04","current":-14.432336,"twenty":-17.33018,"median":-11.139168,"eighty":-9.901443,"marketCap":5105944100},{"date":"2026-09-11","current":-14.329791,"twenty":-17.27056,"median":-11.195675,"eighty":-9.903787,"marketCap":5069665023},{"date":"2026-09-18","current":-14.690599,"twenty":-17.210941,"median":-11.23988,"eighty":-9.921368,"marketCap":5197313626},{"date":"2026-09-25","current":-13.949992,"twenty":-17.164605,"median":-11.372203,"eighty":-9.935823,"marketCap":4935298073},{"date":"2026-10-02","current":-14.280417,"twenty":-17.093203,"median":-11.537867,"eighty":-9.941944,"marketCap":5052197320}],"updateTime":1791056095765},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"DFTX\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2654016935","title":"Definium Therapeutics initiated with an Overweight at Wells Fargo","url":"https://stock-news.laohu8.com/highlight/detail?id=2654016935","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654016935?lang=en_us&edition=fundamental","pubTime":"2026-07-27 17:25","pubTimestamp":1785144321,"startTime":"0","endTime":"0","summary":"Wells Fargo analyst Benjamin Burnett initiated coverage of Definium Therapeutics (DFTX) with an Overweight rating and $68 price target The firm bel...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-initiated-with-an-overweight-at-wells-fargo-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-initiated-with-an-overweight-at-wells-fargo-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PGF","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653817035","title":"Definium Therapeutics Price Target Raised to $73.00/share from $48.00 by Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2653817035","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653817035?lang=en_us&edition=fundamental","pubTime":"2026-07-24 23:11","pubTimestamp":1784905860,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/DFTX/analyst-ratings(END) Dow Jones NewswiresJuly 24, 2026 11:11 ET","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653341089","title":"Definium Therapeutics price target raised to $73 from $48 at Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2653341089","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653341089?lang=en_us&edition=fundamental","pubTime":"2026-07-24 18:55","pubTimestamp":1784890521,"startTime":"0","endTime":"0","summary":"Piper Sandler raised the firm’s price target on Definium Therapeutics (DFTX) to $73 from $48 and keeps an Overweight rating on the shares. The firm...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-price-target-raised-to-73-from-48-at-piper-sandler-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-price-target-raised-to-73-from-48-at-piper-sandler-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653701014","title":"U.S. Research Roundup-deckers Brands, Rollins, United Rentals","url":"https://stock-news.laohu8.com/highlight/detail?id=2653701014","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653701014?lang=en_us&edition=fundamental","pubTime":"2026-07-24 15:14","pubTimestamp":1784877253,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Deckers Brands, Rollins, United RentalsJuly 24 (Reuters)-Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies including Decker","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260724:nL4N43Q0HS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","ROL","FCX","BPOP","DECK","CMCSA","EW","LRCX","NVR","SETM","HON","LMT","PNFP","MISL","DFTX","EMET","DOW","FCNCA","ALK","AMAT","DOV","AMDS","JUP.UK","TINY","AMP","INTC","BX","DOMO","KRMN","LOB","MBWM","PKG","CTSH","AMUU","MEDP","NIC","R","THRM","AMD","MPLT","NSC","GPZ","OBK","SAM","TEK","MOH","FOA","ACI","AAL","CHPS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171650657","title":"Movement Alert｜Definium Therapeutics Rises 5.14% in Regular Trading, Trading at $45.02","url":"https://stock-news.laohu8.com/highlight/detail?id=1171650657","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171650657?lang=en_us&edition=fundamental","pubTime":"2026-07-22 03:50","pubTimestamp":1784663440,"startTime":"0","endTime":"0","summary":"On July 22, Definium Therapeutics rose 5.14% in regular trading, trading at $45.02/share, with Turnover of $39.52 million.Within the Pharmacy sector where Definium Therapeutics belongs, the overall...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653704243","title":"Definium Therapeutics Issues Options for 30,330 Shares to New Hires Under Inducement Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2653704243","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653704243?lang=en_us&edition=fundamental","pubTime":"2026-07-21 04:01","pubTimestamp":1784577692,"startTime":"0","endTime":"0","summary":"Definium Therapeutics issues options for 30,330 shares to new hires under inducement planDefinium Therapeutics issued inducement stock options covering 30,330 common shares to two newly hired non-exec","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260720:nNDLKfSXl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173601696","title":"Movement Alert｜Definium Therapeutics Rises 5.5% in Regular Trading, DT120 Phase 3 Data and Sector M&A Fuel Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=1173601696","media":"Market Focus","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173601696?lang=en_us&edition=fundamental","pubTime":"2026-07-16 21:43","pubTimestamp":1784209420,"startTime":"0","endTime":"0","summary":"On July 16, Definium Therapeutics rose 5.5% in regular trading, trading at $46.5/share, with turnover of $24.58 million.On the news front, multiple catalysts continue to support buying momentum. The...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Definium Therapeutics Rises, DT120 Phase 3 Data and Secto...","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651449575","title":"S&P 500 Futures Decline in Premarket Trading; Ermenegildo Zegna, JB Hunt Transport Lead","url":"https://stock-news.laohu8.com/highlight/detail?id=2651449575","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651449575?lang=en_us&edition=fundamental","pubTime":"2026-07-16 19:30","pubTimestamp":1784201400,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Barrons.com using technology from Automated Insights.With U.S. stock markets set to open in two hours, Ermenegildo Zegna N.V. (ZGN) was up 10.9% in pre-mark","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IJH","FELC","LGH","PTL","UXJA","SNDK","ACLC","GPIX","UNH","UOCT","VOOG","DBB","VOO","SPYU","VHT","CFO","HELO","VYM","XUSP","SCHG","SPYM","VUG","CPST","FEBT","FLCC","IYH","LOHA","XPAY","MRCP","SPGP","FLAO",".SPX","ASTS","PTF","OALC","SPY","PBJL","ZGN","ETFT","JBHT","PEGA","TSPA","CGUS","GBXB","DFTX","BKLC","ISSXF","GSUS","PTLC","BMAY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651319446","title":"Definium Therapeutics Launches Wired for Worry, a Health Care Provider Initiative to Advance the Understanding of Generalized Anxiety Disorder (gad) Patient Impact and Neurobiology","url":"https://stock-news.laohu8.com/highlight/detail?id=2651319446","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651319446?lang=en_us&edition=fundamental","pubTime":"2026-07-16 19:00","pubTimestamp":1784199603,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260716:nTUA2VFM6H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147939149","title":"Movement Alert｜Definium Therapeutics Rises 5.1% in Pre-Market Trading, DT120 Phase 3 Data and Capital Raise Continue to Fuel Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=1147939149","media":"Market Focus","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1147939149?lang=en_us&edition=fundamental","pubTime":"2026-07-16 16:47","pubTimestamp":1784191651,"startTime":"0","endTime":"0","summary":"On July 16, Definium Therapeutics rose 5.1% in pre-market trading, trading at $48.0/share, with turnover of $62,900. The stock continues to rally as multiple positive catalysts sustain buying...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Definium Therapeutics Rises, DT120 Phase 3 Data and Ca...","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158920231","title":"Movement Alert｜Definium Therapeutics Rises 7.03% Overnight, DT120 Phase 3 Data Momentum Continues","url":"https://stock-news.laohu8.com/highlight/detail?id=1158920231","media":"Market Focus","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158920231?lang=en_us&edition=fundamental","pubTime":"2026-07-16 08:48","pubTimestamp":1784162901,"startTime":"0","endTime":"0","summary":"On July 16, Definium Therapeutics rose 7.03% overnight, trading at $48.87 per share, with turnover of $19,100.The continued upward momentum is driven by the sustained positive market reaction to the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142890561","title":"Movement Alert｜Definium Therapeutics Rises 5.04% in After-Hours Trading, Trading at $47.79","url":"https://stock-news.laohu8.com/highlight/detail?id=1142890561","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142890561?lang=en_us&edition=fundamental","pubTime":"2026-07-16 06:58","pubTimestamp":1784156317,"startTime":"0","endTime":"0","summary":"On July 16, Definium Therapeutics rose 5.04% in after-hours trading, trading at $47.79 USD/share, with Turnover of $1.4192 million.Within the Pharmacy sector where Definium Therapeutics belongs,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651111494","title":"Definium Therapeutics (DFTX) Could Be 30% Overvalued After New GAD Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2651111494","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651111494?lang=en_us&edition=fundamental","pubTime":"2026-07-16 06:27","pubTimestamp":1784154476,"startTime":"0","endTime":"0","summary":"What the new GAD study tells investors about Definium Therapeutics stock\nDefinium Therapeutics (DFTX) has put fresh clinical needs in the spotlight with a large healthcare claims study in CNS Spectrums showing many generalized anxiety disorder patients discontinuing or switching treatment far earlier than guidelines suggest.\nFor you as an investor, the findings matter because they quantify how often real world patients move away from current generalized anxiety disorder therapies or...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-dftx/definium-therapeutics/news/definium-therapeutics-dftx-could-be-30-overvalued-after-new","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-dftx/definium-therapeutics/news/definium-therapeutics-dftx-could-be-30-overvalued-after-new","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651486358","title":"Will New GAD Treatment Persistence Data Change Definium Therapeutics' (DFTX) Unmet‑Need Narrative?","url":"https://stock-news.laohu8.com/highlight/detail?id=2651486358","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651486358?lang=en_us&edition=fundamental","pubTime":"2026-07-15 02:43","pubTimestamp":1784054639,"startTime":"0","endTime":"0","summary":"Definium Therapeutics recently reported results from a large U.S. healthcare claims study, published in CNS Spectrums, examining real‑world pharmacotherapy patterns in adults with generalized anxiety disorder between 2020 and 2024.\nThe analysis revealed frequent early discontinuation, rapid switching, and prolonged gaps in care, underscoring substantial unmet need and limited durability of benefit with current GAD treatment options.\nNext, we will explore how this evidence of high...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-dftx/definium-therapeutics/news/will-new-gad-treatment-persistence-data-change-definium-ther","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-dftx/definium-therapeutics/news/will-new-gad-treatment-persistence-data-change-definium-ther","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126761817","title":"Movement Alert｜Definium Therapeutics Rises 5.13% in Regular Trading, Trading at $45.845","url":"https://stock-news.laohu8.com/highlight/detail?id=1126761817","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126761817?lang=en_us&edition=fundamental","pubTime":"2026-07-15 00:38","pubTimestamp":1784047137,"startTime":"0","endTime":"0","summary":"On July 14, Definium Therapeutics rose 5.13% in regular trading, trading at $45.845 USD/share, with Turnover of $23.838 million.Within the Pharmacy sector where Definium Therapeutics belongs, the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651965170","title":"Definium Therapeutics announces results from healthcare claims study in GAD","url":"https://stock-news.laohu8.com/highlight/detail?id=2651965170","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651965170?lang=en_us&edition=fundamental","pubTime":"2026-07-14 19:11","pubTimestamp":1784027482,"startTime":"0","endTime":"0","summary":"Definium Therapeutics (DFTX) announced results from a new healthcare claims study of treatment patterns of newly diagnosed and established GAD pati...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-announces-results-from-healthcare-claims-study-in-gad-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-announces-results-from-healthcare-claims-study-in-gad-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DFTX","VHT","IXJ","BK4550","NOBL","BK4007","CGCV","BK4588","BK4585","TCAF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651779631","title":"Definium Says Claims Study Finds High GAD Drug Discontinuation, Switching Rates","url":"https://stock-news.laohu8.com/highlight/detail?id=2651779631","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651779631?lang=en_us&edition=fundamental","pubTime":"2026-07-14 19:00","pubTimestamp":1784026838,"startTime":"0","endTime":"0","summary":"Definium says claims study finds high GAD drug discontinuation, switching ratesDefinium Therapeutics reported results from a healthcare claims study in CNS Spectrums showing high switching, discontinu","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260714:nNDL3nF15V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113461683","title":"Movement Alert｜Definium Therapeutics Falls 5.44% in Regular Trading, Trading at $44.45","url":"https://stock-news.laohu8.com/highlight/detail?id=1113461683","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113461683?lang=en_us&edition=fundamental","pubTime":"2026-07-13 22:22","pubTimestamp":1783952568,"startTime":"0","endTime":"0","summary":"On July 13, Definium Therapeutics fell 5.44% in regular trading, trading at $44.45 USD/share, with Turnover of $13.26 million.Within the Pharmacy sector where Definium Therapeutics belongs, the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171789885","title":"Movement Alert｜Definium Therapeutics Falls 5.06% in Regular Trading, Trading at $45.96","url":"https://stock-news.laohu8.com/highlight/detail?id=1171789885","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171789885?lang=en_us&edition=fundamental","pubTime":"2026-07-10 21:52","pubTimestamp":1783691561,"startTime":"0","endTime":"0","summary":"On July 10, Definium Therapeutics fell 5.06% in regular trading, trading at $45.96 USD/share, with Turnover of $9.66 million.Within the Pharmacy sector where Definium Therapeutics belongs, the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192883916","title":"Movement Alert｜Definium Therapeutics Rises 5.09% in Regular Trading, Phase 3 Clinical Success and Major Financing Boost Market Confidence","url":"https://stock-news.laohu8.com/highlight/detail?id=1192883916","media":"Market Focus","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192883916?lang=en_us&edition=fundamental","pubTime":"2026-07-09 23:54","pubTimestamp":1783612460,"startTime":"0","endTime":"0","summary":"On July 9, Definium Therapeutics rose 5.09% in regular trading, trading at $47.34 per share with turnover of $67.50 million.The rally continues to be driven by the companys core product DT120 orally...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":6,"totalSize":200,"code":"91000000","status":"200"}]}}